Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Selvedge Venture is a venture capital firm founded by Alasdair Thong and Robert Thong, based in the United States. The firm specializes in early-stage investments, focusing on healthcare innovations that address age-related medical conditions. While specific fund size and assets under management are not disclosed, Selvedge Venture targets impactful solutions in the healthcare sector.
Selvedge Venture invests in startups targeting age-related medical conditions, specifically Metabolic Syndrome, Cancer, and Neurodegenerative Diseases. The firm participates in Pre-Seed, Seed, and Series A funding rounds, utilizing advancements in biotechnology and digital technologies to enhance healthcare outcomes.
Notable portfolio companies include Kytopen, an MIT spin-out focused on engineered cell therapies; Sanome, which develops a human digital twin for early health change detection; and Yuri, providing services for research and commercial applications in microgravity.
Submit through their form at selvedgeventure.com.
Yes, Selvedge Venture often leads funding rounds in the early stages, particularly in Pre-Seed and Seed investments.
The firm is open to follow-on investments, especially if the startup continues to align with their focus on age-related medical conditions.
Specific details about the fund size are not publicly available, but the firm focuses on early-stage investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.